[Federal Register Volume 69, Number 17 (Tuesday, January 27, 2004)]
[Notices]
[Page 3899]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-1726]



[[Page 3899]]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Invaplex From Gram Negative 
Bacteria, Method of Purification and Method of Use

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent No. 6,680,374 
entitled ``Invaplex from Gram Negative Bacteria, Method of Purification 
and Method of Use,'' filed January 31, 2001. The United States 
Government, as represented by the Secretary of the Army, has rights in 
this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Isolated antibodies to Invaplex; novel 
compositions comprising immunoglobulins directed to invasin proteins 
and LPS from gram negative bacteria that selectively bind to Invaplex, 
and do not bind to the individual components of Invaplex.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 04-1726 Filed 1-26-04; 8:45 am]
BILLING CODE 3710-08-M